89 research outputs found
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group.
No full textThe safety of anistreplase from the placebo-controlled aims study (anistreplase intervention mortality study)
No full textSystolic left ventricular function after reperfusion therapy for acute myocardial infarction. Analysis of determinants of improvement. The TAMI Study Group.
No full textDipyridamole echocardiography test. A new tool for detecting jeopardized myocardium after thrombolytic therapy.
No full text
Low-molecular-weight heparins in acute myocardial infarction: RationaLe and results of a pilot study
No full textThrombolytic Therapy Is Indicated for Patients Over 75 Years of Age With ST‐Elevation Acute Myocardial Infarction: Protagonist Viewpoint
No full textIllusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?
No full textEffects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction.
No full text- …
